The impact of preclinical drug safety on R&D productivity.
The Fifth International World Pharmaceutical Congress was held in the Philadelphia Convention Centre during May 23 - 25 2006. In addition to exhibits and three plenary presentations, there were six concurrent sessions. In this report the author summarises some of the highlights of the conference entitled 'The impact of preclinical drug safety on R&D productivity'. This focused session gave a broad overview of the present state and future directions of drug safety assessment, both from a technical and organisational perspective.